Clinical Trial Update: Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) [Phase 3]

View source ↗

Summary

The ROSETTA Phase 3 trial comparing sacral neuromodulation versus botulinum toxin for refractory overactive bladder has completed and results were posted in Mar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence Urge

Drugs mentioned

• OnabotulinumtoxinA (Botox) (Botulinum toxin type A)
• Sacral neuromodulation (sacral nerve stimulator)

Snippet

Sponsor: NICHD Pelvic Floor Disorders Network | Conditions: Urinary Incontinence, Urge | Phase 3 | Status: COMPLETED | Results posted: 2018-03-08